News | April 12, 2026
Eli Lilly launches once-daily weight-loss pill Foundayo
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The event showcased latest breakthroughs in minimally invasive surgery, organ-preservation strategies, and targeted therapies
The event also featured discussions on emerging trends in joint replacement surgery
Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The initiative is a significant step toward combating antimicrobial resistance (AMR) and reducing environmental contamination from antibiotic waste
The collaboration brings together AIG Hospitals’ high-volume clinical expertise, advanced innovation capabilities, and growing artificial intelligence-led healthcare initiatives
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
Former Global Head of IT & Digital Transformation at Biocon Biologics steps into enterprise-wide technology leadership role
Subscribe To Our Newsletter & Stay Updated
